Crescent Capital BDC (NASDAQ:CCAP) Price Target Cut to $18.00 by Analysts at Wells Fargo & Company

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) had its price target cut by stock analysts at Wells Fargo & Company from $19.00 to $18.00 in a report issued on Friday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective indicates a potential downside of 5.16% from the company’s current price.

Separately, Keefe, Bruyette & Woods boosted their price objective on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a research note on Monday, November 25th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $19.17.

Read Our Latest Analysis on CCAP

Crescent Capital BDC Trading Down 5.1 %

Shares of CCAP stock opened at $18.98 on Friday. Crescent Capital BDC has a 1 year low of $16.38 and a 1 year high of $20.19. The company’s fifty day simple moving average is $19.46 and its two-hundred day simple moving average is $18.86. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.26 and a quick ratio of 1.26. The stock has a market capitalization of $703.44 million, a price-to-earnings ratio of 9.67 and a beta of 0.81.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last released its quarterly earnings data on Wednesday, February 19th. The company reported $0.55 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.86%. The company had revenue of $46.40 million for the quarter, compared to the consensus estimate of $47.27 million. As a group, analysts anticipate that Crescent Capital BDC will post 2.09 earnings per share for the current year.

Institutional Investors Weigh In On Crescent Capital BDC

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Montag A & Associates Inc. bought a new position in shares of Crescent Capital BDC in the 4th quarter worth $35,000. C M Bidwell & Associates Ltd. bought a new position in Crescent Capital BDC in the fourth quarter valued at $39,000. Aquatic Capital Management LLC purchased a new stake in Crescent Capital BDC during the fourth quarter valued at about $129,000. Generation Capital Management LLC bought a new stake in Crescent Capital BDC during the fourth quarter worth about $192,000. Finally, Dynamic Technology Lab Private Ltd purchased a new position in shares of Crescent Capital BDC in the 4th quarter worth about $218,000. 49.46% of the stock is owned by hedge funds and other institutional investors.

About Crescent Capital BDC

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

See Also

Analyst Recommendations for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.